Adjuvant topical dorzolamide or timolol with intravitreal bevacizumab for diabetic macular edema: A double-blind randomized controlled trial. J Curr Biomed Rep [Internet]. 2024 Mar. 30 [cited 2026 Apr. 23];5(1):14-9. Available from: https://jcbior.homes.iot-dashnet.ir/index.php/JCBioR/article/view/279